ANTITHROMBOGENE IMPLANTATE
European patent · EP2999494 · In force
Register entry
- Publication number
- EP2999494
- Application number
- EP14800261
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 19, 2014
- Published
- Mar 30, 2016
- Granted
- Sep 16, 2020
- Protection ends at the latest
- May 18, 2034
- Next annual fee due
- May 31, 2026
- IPC classes
- A61L 31/08 (2006.01)
- Priority
- US 201361825256 P 20.05.2013
- PCT application
- PCT/US2014/038597 19.05.2014
- PCT publication
- WO2014/189835 27.11.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 9, 2023
Change
Published in Swissreg on 09.06.2023
- Oct 1, 2020
Agent entered
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 01.10.2020
- Sep 16, 2020
Granted
Published in Swissreg on 16.09.2020
Parties
Inventor
NIKLASON, Laura
Greenwich, Connecticut 06831, US
DIMITRIEVSKA, Sashka
Branford, Connecticut 06405, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.